Sigurd M. Hald
- Oncology top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 10%
- Co-authors
- Roy M. BremnesLill‐Tove BusundTom DønnemSigve AndersenElin RichardsenMehrdad RakaeeSamer Al‐SaadThomas K. Kilvær
- Topics
- Cancer Immunotherapy and Biomarkers (8 papers)Immunotherapy and Immune Responses (5 papers)Lung Cancer Treatments and Mutations (3 papers)
- Cited by
- OncologyImmunologyCancer Research
In The Last Decade
Sigurd M. Hald
12 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Oncology 818
- Immunology 425
- Pulmonary and Respiratory Medicine 410
- Molecular Biology 258
- Cancer Research 193
Countries citing papers authored by Sigurd M. Hald
This map shows the geographic impact of Sigurd M. Hald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigurd M. Hald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigurd M. Hald more than expected).
Fields of papers citing papers by Sigurd M. Hald
This network shows the impact of papers produced by Sigurd M. Hald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigurd M. Hald. The network helps show where Sigurd M. Hald may publish in the future.
Co-authorship network of co-authors of Sigurd M. Hald
This figure shows the co-authorship network connecting the top 25 collaborators of Sigurd M. Hald. A scholar is included among the top collaborators of Sigurd M. Hald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sigurd M. Hald. Sigurd M. Hald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | 58 | |
| 3 | 71 | |
| 4 | 72 | |
| 5 | 362 | |
| 6 | 252 | |
| 7 | 27 | |
| 8 | 12 | |
| 9 | 56 | |
| 10 | 30 | |
| 11 | 53 | |
| 12 | 44 |
About Sigurd M. Hald
Sigurd M. Hald is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (5 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (818 citations), Immunology (425 citations) and Cancer Research (193 citations). Sigurd M. Hald has collaborated with scholars based in Norway and Australia. Frequent co-authors include Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Sigve Andersen, Elin Richardsen, Mehrdad Rakaee, Samer Al‐Saad, Thomas K. Kilvær, Erna‐Elise Paulsen and Khalid Al‐Shibli. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.